-
Health Canada Not in Any Rush to Return Vioxx to Pharmacies
Expert Panel Finds That Vioxx is Safe Enough — But is it, Really? Health Canada is balking, so to speak, at the recommendation of an expert panel it appointed to consider the issue of…
-
Pfizer to Change Its Ways as Regards How the Company Promotes Its Drugs to Consumers
Pfizer Promises to Provide More Detail on Serious Side Effect Risks in DTC Advertisements Pfizer — the world’s largest pharmaceutical company and the biggest "direct to consumer" (DTC) advertiser of prescription drugs — is…
-
FDA Drug Safety Panel Member Composition Is Criticized by Senator Grassley and FDA’s Graham
Concern About Panel’s Independence May Create Support for Pending Grassley-Dodd Bill Due in large part to the types of people who have been appointed as members , Senator Charles E. Grassley (R-Iowa) and FDA…
-
3,017 Baycol / Lipobay Cases Settled by Bayer as of June 30, 2005
Bayer Has Paid Out $1.138 Billion; Average Baycol Settlement is $377,195 On August 10, 2005 it was reported that as of June 30, 2005 Bayer AG has paid $1.138 billion to settle 3,017 injury…
-
Natrecor: Medical Experts Adamant About Their Advice Given to Scios / Johnson & Johnson
Natrecor Advisory Panel Report is Probably Not What Drug Maker Expected, or Wanted In the August 9, 2005 edition of The New York Times, reporter Stephanie Saul succinctly characterized the current Natrecor situation: "Call…
-
MedEffect: The New Drug-safety Web Site from Health Canada
Intended to Collect Adverse Drug Reaction Information from, and for, Canadians On August 9, 2005 Health Canada launched "MedEffect", which is a new web site dedicated to collecting adverse drug reaction reports from Canadian…
